“…Mesenchymal stem cells (MSCs) have consistently been a crucial reservoir of progenitor cells in tissue engineering, and hold great therapeutic promise in preclinical and clinical studies. − Accumulating evidence have suggested that other than directly differentiate into effector cells to replace the tissue, MSCs exhibit a high paracrine activity via exosome release mechanism to regulate the surrounding microenvironment. , Exosomes are a type of nanosized membranous vesicles actively secreted by various cells, and are considered effective paracrine signal mediators by delivering bioactive molecules (including nucleic acids, proteins, and liquids) for intercellular communication and signal transduction. − Numerous researches have demonstrated that MSCs-derived exosomes (MSCs-Exos) exhibit beneficial bone regeneration effects through transporting intercellular biochemicals, and orchestrating multiple biological processes, and could avoid the risks of immune rejection and tumorigenicity from direct MSC transplantation, thus providing promising perspectives for cell-free therapy in regenerative medicine. , Furthermore, significant recent work revealed that MSCs are “environmental responsive” cells, with the bioactive components in their exosomes tunable with histological origin, physicochemical stimulation, and genetic modification. , This suggested that manipulation of exosomes to transfer desired cargoes has important implications in improving their therapeutic potential. However, how to engineer MSCs-Exos with effective neuro- and osteo-promotive effects, and further to promote innervated bone regeneration, remains elusive.…”